Suppression of ethylnitrosourea-induced schwannoma development involves elimination of neu/erbB-2 mutant premalignant cells in the resistant BDIV rat strain.
Contrary to the response of rats of the highly sensitive inbred strain BDIX, BDIV rats are resistant to the induction of malignant schwannomas by exposure to the alkylating N-nitroso carcinogen N-ethyl-N-nitrosourea (EtNU). In BDIX rats, a point mutation at nucleotide 2012 in the transmembrane region of the neu/erbB-2 gene has proved to be a very early marker of initiated Schwann precursor cells with an elevated risk of malignant transformation, and is diagnostic of the resulting schwannomas. To gain insight into the cellular and molecular mechanisms responsible for the resistance of the BDIV strain, comparative quantitative neu mutation analyses combined with histomorphological studies were performed on the trigeminal nerves of EtNU-treated BDIV and BDIX rats as well as on their (BDIX x BDIV) F1 progeny. It was found that neu-mutant Schwann cells are initially present at comparable frequency in the trigeminal nerves of both resistant and sensitive animals. Contrasting with the progressive multiplication of mutant Schwann cells in BDIX trigeminal nerves, however, the numbers of mutant cells began to decrease during the intermediary phase of the carcinogenic process in BDIV animals, and premalignant neu-mutant cells were no longer detectable by the time BDIX rats developed full-blown trigeminal schwannomas. The resistance of BDIV rats thus involves the elimination of initiated neu-mutant Schwann cells during the postinitiation period of EtNU-induced schwannomagenesis via mechanisms that remain to be clarified.
Kindler-Röhrborn
A
A
Institute of Cell Biology (Cancer Research), University of Essen Medical School and West German Cancer Center Essen.
Kind
A B
AB
Koelsch
B U
BU
Fischer
C
C
Rajewsky
M F
MF
D000483:Alleles; D000818:Animals; D002273:Carcinogens; D003390:Cranial Nerve Neoplasms / Q000139:chemically induced / Q000235:genetics* / Q000473:pathology; D003433:Crosses, Genetic; D005038:Ethylnitrosourea; D005260:Female; D018734:Genes, erbB-2 / Q000235:genetics / Q000502:physiology*; D020022:Genetic Predisposition to Disease / Q000235:genetics*; D008297:Male; D009442:Neurilemmoma / Q000139:chemically induced / Q000235:genetics* / Q000473:pathology; D017354:Point Mutation / Q000502:physiology; D011230:Precancerous Conditions / Q000139:chemically induced / Q000235:genetics* / Q000473:pathology; D051381:Rats; D011919:Rats, Inbred Strains; D014276:Trigeminal Nerve / Q000187:drug effects / Q000473:pathology / Q000502:physiology
D002273:Carcinogens; D005038:Ethylnitrosourea